All Stories

  1. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice
  2. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults
  3. Dietary treatment modulates mast cell phenotype, density, and activity in adult eosinophilic oesophagitis
  4. Update on topical steroid therapy for eosinophilic esophagitis
  5. Reply
  6. Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments
  7. Optimised empiric triple and concomitant therapy forHelicobacter pylorieradication in clinical practice: the OPTRICON study
  8. Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis
  9. Bone Metabolism and Osteoporosis in Adult Celiac Disease
  10. Four-food group elimination diet for adult eosinophilic esophagitis: A prospective multicenter study
  11. Serum IgE-targeted elimination diets for treating eosinophilic esophagitis: things are not what they seem
  12. Epidemiology and temporal trends (2000–2012) of inflammatory bowel disease in adult patients in a central region of Spain
  13. Eosinophilic Esophagitis in Adults Is Associated With IgG4 and Not Mediated by IgE
  14. Association between nutritional screening via the Controlling Nutritional Status index and bone mineral density in chronic liver disease of various etiologies
  15. Sedation for gastrointestinal endoscopy
  16. Systematic review: the association between eosinophilic oesophagitis and coeliac disease
  17. Efficacy of Dietary Interventions for Inducing Histologic Remission in Patients With Eosinophilic Esophagitis: A Systematic Review and Meta-analysis
  18. Eosinophilic esophagitis: a practical approach to diagnosis and management
  19. Su1167 European Registry on H. pylori Management (Hp-EuReg): Spanish Detailed Results (Interim Analysis)
  20. Su1164 Second-Line Rescue Therapy With Moxifloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection
  21. 565 Optimized Triple and Concomitant Therapy for Helicobacter pylori Eradication: The OPTRICON Study
  22. Cellular and molecular immunological mechanisms in eosinophilic esophagitis: an updated overview of their clinical implications
  23. Same-day bidirectional endoscopy with nonanesthesiologist administration of propofol
  24. Dietary Management of Patients with Eosinophilic Esophagitis
  25. Propofol administration is safe in adult eosinophilic esophagitis patients sensitized to egg, soy, or peanut
  26. Treatment of Adult Eosinophilic Esophagitis with Diet
  27. Emerging Therapeutic Strategies for Eosinophilic Esophagitis
  28. Dietary therapies for eosinophilic esophagitis
  29. Alcoholic liver disease and changes in bone mineral density
  30. Transcultural adaptation and validation of the Celiac Disease Quality of Life (CD-QOL) survey, a specific questionnaire to measure quality of life in patients with celiac disease
  31. Nutritional assessment with CONUT-index and its relationship with bone mineral density disorders in chronic liver disease of mixed etiology
  32. Causes, evaluation, and consequences of eosinophilic esophagitis
  33. The relationship between proximal and distal colonic adenomas
  34. Tolerance of a cow's milk-based hydrolyzed formula in patients with eosinophilic esophagitis triggered by milk
  35. Metabolismo óseo y osteoporosis en la enfermedad celíaca
  36. Diagnostic and therapeutic management of eosinophilic oesophagitis in children and adults: Results from a Spanish registry of clinical practice
  37. Dermatitis herpetiformis: what lies beneath the skin?
  38. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: A prospective study on the food cause of the disease
  39. Bone mineral density in adult coeliac disease: An updated review
  40. Urticaria pigmentosa in a female patient with celiac disease: Response to a gluten-free diet
  41. Prevalence of eosinophilic oesophagitis in adult patients in a central region of Spain
  42. Colonoscopy in Obese Patients: Time to Change Position
  43. Adult versus pediatric eosinophilic esophagitis: important differences and similarities for the clinician to understand
  44. Transmural Eosinophilic Infiltration and Fibrosis in a Patient With Non-Traumatic Boerhaave's Syndrome Due to Eosinophilic Esophagitis
  45. Eosinophilic gastroenteritis: an update
  46. Nutritional treatment in inflammatory bowel disease: An update
  47. Author reply: Comment to “Prevalence and incidence of microscopic colitis in patients with diarrhoea of unknown aetiology in a region in central Spain”
  48. Nonanesthesiologist-administered propofol sedation for colonoscopy is safe and effective
  49. Bone mineral density directly correlates with duodenal Marsh stage in newly diagnosed adult celiac patients
  50. Prevalence and incidence of microscopic colitis in patients with diarrhoea of unknown aetiology in a region in central Spain
  51. Otras esofagitis. Etiología infecciosa y tóxica/cáustica. Esofagitis eosinofílica
  52. Successful Food Elimination Therapy in Adult Eosinophilic Esophagitis
  53. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: A prospective study
  54. Choking on food deaths in a case series of psychiatric patients. A retrospective study of risk factors
  55. Nutrición por PEG en pacientes con demencia: más allá de la evidencia
  56. Eosinophilic esophagitis: Updated consensus recommendations for children and adults
  57. Montelukast Was Inefficient in Maintaining Steroid-Induced Remission in Adult Eosinophilic Esophagitis
  58. Gastrostomía endoscópica percutánea: una actualización sobre indicaciones, técnica y cuidados de enfermería
  59. Review: Nutritional and Dietary Aspects of Celiac Disease
  60. Esophageal manifestations of celiac disease
  61. Tracheal Aspiration of a Capsule Endoscope: A New Case Report and Literature Compilation of an Increasingly Reported Complication
  62. Boerhaave's syndrome as the primary manifestation of adult eosinophilic esophagitis. Two case reports and a review of the literature
  63. Coeliac Disease in the 21st Century: No Longer “Kids’ Stuff”
  64. Small bowel video capsule endoscopy in Crohn’s disease: What have we learned in the last ten years?
  65. Treatment of Eosinophilic Esophagitis
  66. Adult Patients with Eosinophilic Esophagitis Do Not Show an Increased Frequency of the HLA-DQ2/DQ8 Genotypes Predisposing to Celiac Disease
  67. Eosinophilic diseases of the gastrointestinal tract
  68. An update on the immunopathogenesis of eosinophilic esophagitis
  69. Eosinophilic Esophagitis: Current Aspects of a Recently Recognized Disease
  70. Enteroscopia total intraoperatoria urgente con colonoscopio en hemorragia digestiva baja grave mediante doble enterotomía
  71. The role of mast cells in eosinophilic esophagitis
  72. S1035 The Risk of Severe Crohn's Disease: Validation of a Clinical Prediction Rule
  73. S1874 Chromoendoscopy with Indigo-Carmine Improves the Recognition of Endoscopic Mucosal Findings in Adult Eosinophilic Esophagitis
  74. RIESGO DE DESARROLLAR UNA ENFERMEDAD DE CROHN GRAVE TRAS EL DIAGNÓSTICO: VALIDACIÓN EN POBLACIÓN ESPAÑOLA DE CRITERIOS CLÍNICOS PREDICTIVOS PROPUESTOS
  75. Importance of nutrition in inflammatory bowel disease
  76. Eosinophilic esophagitis: clinical manifestations, diagnosis, and treatment
  77. Treatment With Topical Steroids Downregulates IL-5, Eotaxin-1/CCL11, and Eotaxin-3/CCL26 Gene Expression in Eosinophilic Esophagitis
  78. Immunopathological mechanisms of eosinophilic oesophagitis
  79. Immunopathological mechanisms of eosinophilic oesophagitis
  80. Esophageal Granular Cell Tumor and Eosinophilic Esophagitis: Two Interesting Entities Identified in the Same Patient
  81. Esofagitis eosinofílica
  82. Granular cell tumors of the esophagus: report of five cases and review of diagnostic and therapeutic techniques
  83. Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series
  84. Manometric findings in adult eosinophilic oesophagitis: a study of 12 cases
  85. Esofagitis eosinofílica
  86. Esofagitis eosinofílica. Revisión de los conceptos fisiopatológicos y clínicos actuales
  87. Immunophenotypic Characterization and Quantification of the Epithelial Inflammatory Infiltrate in Eosinophilic Esophagitis Through Stereology
  88. Endoscopic dilation in eosinophilic esophagitis: a treatment strategy associated with a high risk of perforation
  89. Motor disturbances participate in the pathogenesis of eosinophilic oesophagitis, beyond the fibrous remodelling of the oesophagus
  90. P93 Immunological capacity of esophagus: a stereological study in eosinophilic esophagitis
  91. Pancreatitis aguda leve y déficit de proteína C como causas de trombosis venosa mesentérica
  92. Enfermedad celíaca en adultos: Un espectro clínico diferente
  93. Descriptive Study of Food and Aeroallergen Sensitizations in Eosinophilic Esophagitis
  94. Food Allergies and Eosinophilic Esophagitis – Two Case Studies
  95. Eosinofilia y enteritis actínica secundarias a radioterapia por adenocarcinoma de próstata
  96. Varón joven con esofagitis eosinofílica, una nueva causa de disfagia
  97. Bruising of the esophagus as a cause of gastrointestinal bleeding in a case of heatstroke
  98. Cuidados de enfermería en el paciente con cáncer de cabeza y cuello tratado con radioterapia
  99. Eosinophilic esophagitis in adults, an emerging cause of dysphagia: Description of 9 cases
  100. Réplica de los autores
  101. Case Report: Eosinophilic Esophagitis in Adults: An Emerging Disease
  102. Infusores elastoméricos en la administración de fármacos
  103. Prevención y tratamiento de las extravasaciones de quimioterapia intravenosa
  104. El informe de alta de enfermería, un instrumento para la continuidad de los cuidados
  105. Administración de quimioterapia intravenosa en el paciente oncológico